Peter Gunning

ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.

Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland.

Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown.

Powerstax Ltd. designs, manufactures and sells power conversion systems. It specializes in the design and manufacture of AC-DC and DC-DC power supplies including DC-DC converters, transformer rectifiers, configurable, modular and bulk power switched mode power supplies. The firm provides value-added and custom power supply solutions for markets including defence, medical, electro-chlorination, cathodic protection, aerospace, fuel cells, oil and gas and others. The company was founded in 1992 and is headquartered in Farnborough, the United Kingdom.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia.

American Australian Association is a non-profit organization whose purpose is to promote friendship, cooperation and understanding between the peoples of the United States and Australia through a better understanding of their cultures and societies. The company was founded by Keith Murdoch in 1948 and is headquartered in New York, NY.

Biomer Technology Ltd. designs and develops biomaterial products for medical device industry. It develops medical device and therapeutic applications, and engineered polymers; designing and manufacturing industrial grade polymers, including high temperature polyurethanes HTTPU’s, for component and device manufacture. The company was founded in 2003 by Iain Gladstone Ross and is headquartered in Runcorn, the United Kingdom.

Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The company is based in Kobe, Japan.

Part of Pharmaron Beijing Co., Ltd., Allergan Biologics Ltd. develops biologics products. The company is based in Liverpool, UK. The British company was founded in 2002 by Bernard Chan. Allergan Biologics was acquired by Pharmaron Biologics (UK) Holdings Ltd. from AbbVie, Inc. on April 30, 2021 for $165.95 million.

The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin.

Part of Kazia Therapeutics Ltd., Triaxial Pharmaceuticals Pty Ltd. is an Australian company that develops bio-pharmaceutical technologies. The company is based in Sydney, Australia. Triaxial Pharmaceuticals was acquired by Kazia Therapeutics Ltd. on December 06, 2012 for $3.08 million.

Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors.

Eli Lilly Australia Pty Ltd. manufactures and supplies pharmaceutical products. It develops medicines for diabetes, cancer, immunology, and pain. The company was founded in 1960 and is headquartered in West Ryde, Australia.

HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015.